I
IdentifySensors
CHECK4-COVID's nanosensor technology is intended to provide fast and accurate molecular detection of viral pathogens
About IdentifySensors
IdentifySensors Biologics Corp., founded in June 2020 by Dr. Greg Hummer and Matthew Hummer, is a bio-nanotechnology company developing an advanced graphene-based biosensor platform for gene detection. Dr. Hummer, who serves as CEO, is a trauma surgeon with a background in chemistry, computer science, and has founded two other healthcare technology companies. Co-founder Matthew Hummer specializes in data science and analytics. The company, based in Shaker Heights, Ohio, with an R&D facility in Gainesville, Florida, aims to shift molecular diagnostics from slow, chemical-based laboratory processes to a rapid, electronic method.
The core of its business is the Check4® platform, a digital diagnostic system designed to detect pathogens at the molecular gene level from a saliva sample in minutes. This technology utilizes printed graphene-based electronic biosensors on a semiconductor chip to identify the specific genetic material of viruses and bacteria without the need for chemical reagents or enzymatic amplification. The platform consists of two main components: a reusable, portable Bluetooth reader and single-use, disposable test cartridges. Each cartridge can be programmed to detect multiple infections simultaneously. Results are transmitted from the reader to a user's smartphone app or a clinical database.
The company operates on a razor-razorblade business model. It plans to sell the reusable reader and generate recurring revenue from the sale of disposable test cartridges, which will vary in price depending on the complexity of the test. The target market includes both consumers for over-the-counter use and healthcare organizations such as doctor's offices and hospitals. While the technology is still pre-revenue, IdentifySensors initiated the FDA submission process in the second quarter of 2025, starting with a pre-Emergency Use Authorization (EUA) application for a rapid Ebola test. Having raised over $20 million, the company is focused on scaling production and expanding its pipeline of tests for various infectious diseases.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2006
- Headquarters
- Shaker Heights, United States
- Employees
- 10
- Open positions
- None listed
- Dealroom signal
- 70.3/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Health Diagnostics, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Mar 2025 | $20M | $80M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for IdentifySensors is 1.7K monthly website visits, up 13.3% over the last three months. IdentifySensors's team declined 16.7% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
IdentifySensors in the Shaker Heights ecosystem
The IdentifySensors office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about IdentifySensors on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See IdentifySensors’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









